AQST
Price
$4.03
Change
+$0.02 (+0.50%)
Updated
Jul 14 closing price
Capitalization
383.26M
28 days until earnings call
CPHI
Price
$1.89
Change
-$0.01 (-0.53%)
Updated
Jul 14 closing price
Capitalization
18.31M
Interact to see
Advertisement

AQST vs CPHI

Header iconAQST vs CPHI Comparison
Open Charts AQST vs CPHIBanner chart's image
Aquestive Therapeutics
Price$4.03
Change+$0.02 (+0.50%)
Volume$1.11M
Capitalization383.26M
China Pharma Holdings
Price$1.89
Change-$0.01 (-0.53%)
Volume$112.28K
Capitalization18.31M
AQST vs CPHI Comparison Chart in %
Loading...
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AQST vs. CPHI commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AQST is a StrongBuy and CPHI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 15, 2025
Stock price -- (AQST: $4.03 vs. CPHI: $1.89)
Brand notoriety: AQST and CPHI are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AQST: 66% vs. CPHI: 102%
Market capitalization -- AQST: $383.26M vs. CPHI: $18.31M
AQST [@Pharmaceuticals: Other] is valued at $383.26M. CPHI’s [@Pharmaceuticals: Other] market capitalization is $18.31M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AQST’s FA Score shows that 0 FA rating(s) are green whileCPHI’s FA Score has 0 green FA rating(s).

  • AQST’s FA Score: 0 green, 5 red.
  • CPHI’s FA Score: 0 green, 5 red.
According to our system of comparison, both AQST and CPHI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AQST’s TA Score shows that 5 TA indicator(s) are bullish while CPHI’s TA Score has 4 bullish TA indicator(s).

  • AQST’s TA Score: 5 bullish, 4 bearish.
  • CPHI’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both AQST and CPHI are a good buy in the short-term.

Price Growth

AQST (@Pharmaceuticals: Other) experienced а +8.92% price change this week, while CPHI (@Pharmaceuticals: Other) price change was +11.18% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +63.90%. For the same industry, the average monthly price growth was +5.32%, and the average quarterly price growth was +69.68%.

Reported Earning Dates

AQST is expected to report earnings on Nov 10, 2025.

CPHI is expected to report earnings on May 14, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+63.90% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AQST($383M) has a higher market cap than CPHI($18.3M). AQST YTD gains are higher at: 13.202 vs. CPHI (-18.710). CPHI has less debt than AQST: CPHI (5.39M) vs AQST (33.3M).
AQSTCPHIAQST / CPHI
Capitalization383M18.3M2,093%
EBITDA1.18MN/A-
Gain YTD13.202-18.710-71%
P/E RatioN/AN/A-
Revenue50.6MN/A-
Total Cash23.9MN/A-
Total Debt33.3M5.39M617%
FUNDAMENTALS RATINGS
AQST vs CPHI: Fundamental Ratings
AQST
CPHI
OUTLOOK RATING
1..100
2213
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
3834
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
15n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AQST's Valuation (38) in the Pharmaceuticals Major industry is in the same range as CPHI (44) in the Pharmaceuticals Generic industry. This means that AQST’s stock grew similarly to CPHI’s over the last 12 months.

AQST's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as CPHI (100) in the Pharmaceuticals Generic industry. This means that AQST’s stock grew similarly to CPHI’s over the last 12 months.

CPHI's SMR Rating (97) in the Pharmaceuticals Generic industry is in the same range as AQST (100) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew similarly to AQST’s over the last 12 months.

CPHI's Price Growth Rating (34) in the Pharmaceuticals Generic industry is in the same range as AQST (38) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew similarly to AQST’s over the last 12 months.

CPHI's P/E Growth Rating (100) in the Pharmaceuticals Generic industry is in the same range as AQST (100) in the Pharmaceuticals Major industry. This means that CPHI’s stock grew similarly to AQST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AQSTCPHI
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 5 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AQST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CPHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SFBS83.000.97
+1.18%
ServisFirst Bancshares
RVSN0.34N/A
+1.00%
Rail Vision Ltd
TLSA1.48N/A
N/A
Tiziana Life Sciences Ltd
FTV52.17-0.52
-0.99%
Fortive Corp
AMC3.29-0.04
-1.20%
AMC Entertainment Holdings

AQST and

Correlation & Price change

A.I.dvisor indicates that over the last year, AQST has been loosely correlated with SCYX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AQST jumps, then SCYX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AQST
1D Price
Change %
AQST100%
+0.50%
SCYX - AQST
35%
Loosely correlated
+16.50%
DERM - AQST
31%
Poorly correlated
+3.64%
OGI - AQST
31%
Poorly correlated
+2.07%
ESPR - AQST
31%
Poorly correlated
-0.84%
TLRY - AQST
31%
Poorly correlated
+13.14%
More

CPHI and

Correlation & Price change

A.I.dvisor tells us that CPHI and TAK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CPHI and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CPHI
1D Price
Change %
CPHI100%
-0.68%
TAK - CPHI
25%
Poorly correlated
+2.45%
HCM - CPHI
24%
Poorly correlated
+1.18%
PAHC - CPHI
22%
Poorly correlated
+2.40%
SXTC - CPHI
22%
Poorly correlated
-5.14%
ASRT - CPHI
22%
Poorly correlated
-3.44%
More